hVIVO plc (AIM:HVO)
London · Delayed Price · Currency is GBP · Price in GBX 6.00
-0.10 (-1.64%)
Oct 2, 2026, 4:42 PM GMT
hVIVO Market Cap
hVIVO has a market cap or net worth of 41.22 million as of October 2, 2026. Its market cap has decreased by -22.33% in one year.
Market Cap
41.22M
Enterprise Value
41.71M
Revenue
49.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.00
ChartMarket Cap Chart
Since July 1, 2019, hVIVO's market cap has increased from 17.24M to 41.22M, an increase of 139.13%. That is a compound annual growth rate of 12.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 41.22M | -3.83% |
| Dec 31, 2025 | 42.86M | -69.27% |
| Dec 31, 2024 | 139.48M | -13.68% |
| Dec 29, 2023 | 161.59M | 140.84% |
| Dec 30, 2022 | 67.09M | -56.52% |
| Dec 31, 2021 | 154.31M | -10.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 1, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 192.76B |
| GSK plc | 74.37B |
| Haleon | 29.69B |
| Smith & Nephew | 8.51B |
| Creo Medical Group | 53.34M |
| Ondine Biomedical | 50.66M |
| Abingdon Health | 47.86M |
| Sareum Holdings | 42.26M |